Pharmaceutical Technology on MSN6d
USPTO allows patents for Remedy’s large hemispheric infarction drug
The US Patent and Trademark Office (USPTO) has allowed two new patents for Remedy Pharmaceuticals’ Cirara, aimed at treating ...
Remedy Pharmaceuticals Secures Key U.S. Patent Allowance for CIRARA® in Treating Large Hemispheric Infarction, Including Wake-Up Strokes
Remedy Pharmaceuticals, a leader in stroke drug development, today announced that the U.S. Patent and Trademark Office (USPTO) has allowed two additional patents covering its large hemispheric ...
Medscape13d
Secondary Prevention Measures After a Stroke-Should They Target Stroke or Heart Disease?
Half of the patients (51.3%) had a mild stroke (rating of 0-5 on the NIH Stroke Scale [NIHSS]), 32.3% had a stroke of moderate severity (NIHSS rating 6-13) and 16.5% had a severe stroke (NIHSS ...
jnis.bmj16d
Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial
Baseline characteristics among HEP+ and HEP− patients were similar except HEP+ patients had a lower NIH Stroke Scale (NIHSS) score (17 vs 19; p=0.04), lower IV tissue plasminogen activator use (38% vs ...
Medscape2d
Successful Implementation of the National Institutes of Health Stroke Scale on a Stroke/Neurovascular Unit
The National Institutes of Health Stroke Scale (NIHSS) is accepted as the definitive clinical examination to assess stroke severity. This project examined barriers to implementation and NIHSS use ...
verywellhealth23d
Signs and Symptoms of Stroke
Strokes are treatable, so it is important to be able to recognize a stroke so that you can get the right emergency treatment as quickly as possible. If you see or experience any of the following ...